OK - time for a reality check on these blessed statistics.
Let’s say 100 people are diagnosed with this cancer.
There is currently nothing to suggest that the 60 who are currently cured by SOC won’t also be cured by azer-cell (this is what ongoing trials will reveal).
BUT what the 57% results here are implying is that an ADDITIONAL 23 of those 100 couldl also be cured.
That’s 83 people as opposed to 60.
Potentially the cure rate suddenly jumps to 83%
83 people out of every 100 instead 60.
This is 38% better than our 60% at current SOC, more than a third better.
Now, obviously the complexities are such that ongoing trials will reveal whether any of our 100 people wouldn’t respond to azer-cell.
But let’s imagine the day when the tables are reversed and azer-cell is the SOC and the far more brutal regime of the current SOC remains necessary for the poor few for whom azer-cell might not work.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)